Capmatinib Dosage and Administration Guide

Capmatinib is produced by Novartis Pharmaceuticals.FDA (U.S. Food and Drug Administration) approved drug. As a targeted drug targeting mesenchymal epithelial transition (MET) exon 14 skipping mutations, its correct usage and dosage are crucial for patients. This article will introduce the usage and dosage of capmatinib in detail to help patients better understand and use this drug.

First, the recommended use of capmatinib is oral, where the drug is swallowed through the mouth. Patients should swallow the medication whole and avoid breaking, crushing or chewing it to ensure slow release and stable absorption of the medication in the body.

Regarding dosage, doctors will develop a personalized medication plan based on the patient's specific conditions, such as age, weight, severity of illness and other factors. Therefore, patients should consult their doctor in detail before using capmatinib to understand their dosage. Typically, the usual dose of capmatinib is 400 mg twice daily. If you experience adverse reactions, your treating physician may adjust the dose of the drug based on your specific situation, or choose to suspend or even permanently terminate treatment.

When using capmatinib, patients need to pay special attention to the accuracy and regularity of medication. Do not change the dosage or time of medication at will, so as not to affect the efficacy of the medication or increase unnecessary risks. If you miss a dose or vomit after taking it, do not take the extra dose; just continue taking it at your next scheduled regular time.

In addition, patients should pay close attention to any abnormal reactions or discomfort while taking capmatinib. If serious adverse reactions occur, such as difficulty breathing, palpitations, chest pain, etc., you should seek medical treatment immediately and inform the doctor that you are using capmatinib.

According to inquiries, capmatinib is currently not approved in China and patients need to purchase it from overseas. Please be sure to go through formal channels to ensure drug safety.